This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
According to recently published research from the United States, combination gene therapy with p53 and Thoc1/p84 is more effective than either single agent in an animal model of human pancreatic adenocarcinoma.
We care about your feedback. Let us know how we can improve your CancerCompass experience.